Market Cap
Haleon plc Market Capitalization:
£30.55 Billion
GBP as of Jan. 1, 2024
US$38.90 Billion
Haleon plc Main Stock Listing
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
Zoetis Inc.
|
$89.09 B |
MERCK Kommanditgesellschaft auf Aktien
|
$67.64 B |
Takeda Pharmaceutical Company Limited
|
$47.71 B |
|
PPD, Inc.
|
$16.58 B |
|
Eisai Co. Ltd
|
$14.86 B |
Sector: Healthcare
| Company | Market Cap (USD) |
|---|---|
|
Lilly
|
$586.39 B |
|
UnitedHealth Group
|
$504.47 B |
Novo Nordisk
|
$461.52 B |
|
Johnson & Johnson
|
$387.50 B |
|
Merck
|
$296.51 B |
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Company Description
Haleon plc, headquartered in Brentford, UK, specializes in the R&D, manufacture, and sale of consumer healthcare products across various regions. Their offerings encompass therapeutic oral health, pain relief, respiratory, digestive products, and vitamins and supplements. Key brands include Panadol, Voltaren, Advil, Sensodyne, and Centrum.
United Kingdom
What is a company's market capitalization?
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.